These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23488877)

  • 1. Anti-infective carbonic anhydrase inhibitors: a patent and literature review.
    Capasso C; Supuran CT
    Expert Opin Ther Pat; 2013; 23(6):693-704. PubMed ID: 23488877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors: an editorial.
    Supuran CT
    Expert Opin Ther Pat; 2013; 23(6):677-9. PubMed ID: 23461558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial, fungal and protozoan carbonic anhydrases as drug targets.
    Capasso C; Supuran CT
    Expert Opin Ther Targets; 2015; 19(12):1689-704. PubMed ID: 26235676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013).
    Carta F; Supuran CT
    Expert Opin Ther Pat; 2013; 23(6):681-91. PubMed ID: 23488823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based drug discovery of carbonic anhydrase inhibitors.
    Supuran CT
    J Enzyme Inhib Med Chem; 2012 Dec; 27(6):759-72. PubMed ID: 22468747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiglaucoma carbonic anhydrase inhibitors: a patent review.
    Masini E; Carta F; Scozzafava A; Supuran CT
    Expert Opin Ther Pat; 2013; 23(6):705-16. PubMed ID: 23627893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase inhibitors drug design.
    McKenna R; Supuran CT
    Subcell Biochem; 2014; 75():291-323. PubMed ID: 24146385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiobesity carbonic anhydrase inhibitors: a literature and patent review.
    Scozzafava A; Supuran CT; Carta F
    Expert Opin Ther Pat; 2013; 23(6):725-35. PubMed ID: 23607332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007 - 2009.
    Poulsen SA
    Expert Opin Ther Pat; 2010 Jun; 20(6):795-806. PubMed ID: 20476848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013).
    Monti SM; Supuran CT; De Simone G
    Expert Opin Ther Pat; 2013; 23(6):737-49. PubMed ID: 23672415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on carbonic anhydrase inhibitors: a patent review (2008 - 2011).
    Aggarwal M; McKenna R
    Expert Opin Ther Pat; 2012 Aug; 22(8):903-15. PubMed ID: 22788994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfonamides: a patent review (2008 - 2012).
    Carta F; Scozzafava A; Supuran CT
    Expert Opin Ther Pat; 2012 Jul; 22(7):747-58. PubMed ID: 22697257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial carbonic anhydrase inhibitors: an update on the recent literature.
    Supuran CT; Capasso C
    Expert Opin Ther Pat; 2020 Dec; 30(12):963-982. PubMed ID: 32806966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors and activators for novel therapeutic applications.
    Supuran CT
    Future Med Chem; 2011 Jul; 3(9):1165-80. PubMed ID: 21806379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016).
    Lomelino C; McKenna R
    Expert Opin Ther Pat; 2016 Aug; 26(8):947-56. PubMed ID: 27387065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas.
    Supuran CT
    Expert Opin Ther Pat; 2018 Oct; 28(10):709-712. PubMed ID: 30217119
    [No Abstract]   [Full Text] [Related]  

  • 17. Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018).
    Nocentini A; Supuran CT
    Expert Opin Ther Pat; 2018 Oct; 28(10):729-740. PubMed ID: 30074415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Bacterial Carbonic Anhydrases as a Novel Approach to Escape Drug Resistance.
    Capasso C; Supuran CT
    Curr Top Med Chem; 2017; 17(11):1237-1248. PubMed ID: 28049405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The η-class carbonic anhydrases as drug targets for antimalarial agents.
    Supuran CT; Capasso C
    Expert Opin Ther Targets; 2015 Apr; 19(4):551-63. PubMed ID: 25495426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.
    Supuran CT
    Nat Rev Drug Discov; 2008 Feb; 7(2):168-81. PubMed ID: 18167490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.